Simon Messing

NCI RAS Initiative,

Cancer Research Technology Program,

NCI RAS Initiative, Cancer Research Technology Program

Frederick National Laboratory for Cancer Research

Simon Messing trained as structural biologist with Dr. Mario Amzel at Johns Hopkins School of Medicine, where he received a Ph.D. while investigating Nudix hydrolases and plant dioxygenases. As a post-doctoral fellow at NIH with Dr. Frederick Dyda he studied transposition, and worked on several transposases, ultimately solving the structure of a new class of transposases TnpA(REP). Simon is now at Frederick National Labs, and is a part of the RAS Initiative, helping to find novel drug targets of RAS and its associated proteins.

We use cookies to enhance your experience on our website.

By continuing to use our website or clicking “Continue”, you are agreeing to accept our cookies.

Learn More